Dermatomyositis Unknown Status Phase 2 Trials for Abatacept (DB01281)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01315938Abatacept Treatment in Polymyositis and DermatomyositisTreatment